Surveillance of basaloid oral squamous cell carcinoma: the value of [18F]FDG-PET

Oral Oncology ◽  
2004 ◽  
Vol 40 (1) ◽  
pp. 56-62 ◽  
Author(s):  
Martin Kunkel ◽  
Andreas Helisch ◽  
Torsten E Reichert ◽  
Peter Bartenstein ◽  
Wilfried Wagner
Head & Neck ◽  
2008 ◽  
Vol 30 (11) ◽  
pp. 1488-1496 ◽  
Author(s):  
Monica Pentenero ◽  
Angela Cistaro ◽  
Mario Brusa ◽  
Maria Maddalena Ferraris ◽  
Carla Pezzuto ◽  
...  

Oral Oncology ◽  
2006 ◽  
Vol 42 (3) ◽  
pp. 297-305 ◽  
Author(s):  
Martin Kunkel ◽  
Andreas Helisch ◽  
Torsten E. Reichert ◽  
Jong-Hyeon Jeong ◽  
Hans-Georg Buchholz ◽  
...  

Oral Oncology ◽  
2003 ◽  
Vol 39 (2) ◽  
pp. 170-177 ◽  
Author(s):  
Martin Kunkel ◽  
Gregor J Förster ◽  
Torsten E Reichert ◽  
Joachim Kutzner ◽  
Peter Benz ◽  
...  

2014 ◽  
Vol 72 (9) ◽  
pp. e155
Author(s):  
T. Morikawa ◽  
E. Futoo ◽  
A. Funakoshi ◽  
H. Bessho ◽  
T. Yakushiji ◽  
...  

2013 ◽  
Vol 54 (10) ◽  
pp. 1703-1709 ◽  
Author(s):  
N.-M. Cheng ◽  
Y.-H. Dean Fang ◽  
J. Tung-Chieh Chang ◽  
C.-G. Huang ◽  
D.-L. Tsan ◽  
...  

2021 ◽  
pp. 028418512198897
Author(s):  
Alexey Surov ◽  
Maciej Pech ◽  
Alexander Eckert ◽  
Christoph Arens ◽  
Oliver Grosser ◽  
...  

Background Head and neck squamous cell carcinoma (HNSCC) is a common cancer. Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) is a widely used imaging modality in HNSCC. Purpose To provide evident data about associations between 18F-FDG PET and histopathology in HNSCC. Material and Methods The MEDLINE database was screened for associations between maximum standard uptake values (SUVmax) derived from 18F-FDG PET and histopathological features in HNSCC up to May 2020. Only papers containing correlation coefficients between SUVmax and histopathology were acquired. Overall, 23 publications were collected. Results The following correlations were calculated: KI 67: 12 studies (345 patients), pooled correlation coefficient (PCC): 0.23 (95% confidence interval [CI] 0.06–0.40); hypoxia-inducible factor-1α: eight studies (240 patients), PCC: 0.24 (95% CI 0.06–0.42); microvessel density: three studies (64 patients), PCC: 0.33 (95% CI 0.02–0.65); vascular endothelial growth factor: two studies (59 cases), PCC: 0.27 (95% CI 0.02–0.51); tumor suppressor protein p53: four studies (159 patients), PCC: 0.05 (95% CI –0.41 to 0.51); epidermal growth factor receptor: two studies (124 patients), PCC: 0.21 (95% CI 0.05–0.37); tumor cell count: three studies (67 patients), PCC: 0.18 (95% CI –0.06 to 0.42); tumor cell apoptosis: two studies (40 patients), PCC: 0.07 (95% CI = –0.85 to 0.99); B-cell lymphoma-2 protein: two studies (118 patients); PCC: 0.04 (95% CI –0.65 to 0.74); glucose-transporter 1: 10 studies (317 patients), PCC: 0.20 (95% CI 0.10–0.30). Conclusion SUVmax derived from 18F-FDG PET cannot reflect relevant histopathological features in HNSCC.


Sign in / Sign up

Export Citation Format

Share Document